Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

DOI Full Paper Access

115

Citations

25

References

2017

Year

Richard Vickers, Glenn Tillotson, Richard Nathan, Sabine Hazan, John Pullman, Christopher Lucasti, Kenneth Deck, Bruce Yacyshyn, Benedict Maliakkal, Yves Pesant,

The Lancet Infectious Diseases

Abstract

Wellcome Trust and Summit Therapeutics.

References

	Year	Citations

Page 1